Alexandra Andersson, PhD,  —

Alexandra holds a BSc in psychology with continued studies in neuroscience and pharmacology. She also holds an interdisciplinary Med. licentiate merging the fields of neuropharmacology, psychiatry and immunology. Her previous research focused on interaction between the immune- and neurotransmitter systems regarding psychotic disorders.

Articles by Alexandra Andersson

Insights into Rare Disease May Lead to Novel Therapeutic Targets for Parkinson’s

The rare lysosomal storage disorder Krabbe’s disease is caused by an enzyme deficiency and has been found to have surprising similarities with neurodegenerative disorders, including Parkinson’s disease. Establishing this connection can be a valuable tool for developing novel therapeutic targets and new biomarkers for identifying patients at risk for developing Parkinson’s.